NIH Suspends Operations In Pharmaceutical Development Section After Fungal Contamination Discovered.

reports that the National Institutes of Health “has suspended operations” of its Pharmaceutical Development Section, which manufactures medications for clinical research, after the discovery during an inspection of the facilities by the Food and Drug Administration, conducted “between May 19 and May 29,” that two vials of albumin, used in administering interleukin, were contaminated with the fungus aspergillus, and an unnamed “non-human pathogen.” NIH is seeking alternative sources for medications, and so far has “found no evidence of patient harm.” http://www.washingtonpost.com/national/health-science/nih-suspends-operations-of-drug-unit-after-fungal-contamination-in-vials/2015/06/04/b6218cd6-0af6-11e5-9e39-0db921c47b93_story.html